As of June 2025 Sino Biopharmaceutical has a market cap of A$19.98 Billion. This makes Sino Biopharmaceutical the world's 1424th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | A$19.98 B | 64.09% |
2024 | A$12.17 B | -0.67% |
2023 | A$12.26 B | -24.86% |
2022 | A$16.31 B | -10.3% |
2021 | A$18.19 B | -23.85% |
2020 | A$23.88 B | -5.06% |
2019 | A$25.16 B | 113.4% |
2018 | A$11.79 B | -29.95% |
2017 | A$16.83 B | 132.52% |
2016 | A$7.23 B | -21.88% |
2015 | A$9.26 B | 69.36% |
2014 | A$5.47 B | 24.55% |
2013 | A$4.39 B | 93.57% |
2012 | A$2.26 B | 58.47% |
2011 | A$1.43 B | -20.96% |
2010 | A$1.81 B | 11.5% |
2009 | A$1.62 B | 272.73% |
2008 | A$0.43 B | -9.46% |
2007 | A$0.48 B | 41.69% |
2006 | A$0.33 B | -46.44% |
2005 | A$0.63 B | 75.37% |
2004 | A$0.36 B |